All In MedTech

Device Trial Radar · NCT07742787

Renal Denervation in Chronic Kidney Disease - RDN-CKD Study

Effect of Renal Denervation on Blood Pressure in Patients With Chronic Kidney Disease and Uncontrolled Hypertension

Last checked: Nov 20, 2026Latest source record: Aug 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

20

Actual

Start

Jul 4, 2024

Primary completion

Sep 6, 2026

Study completion Mar 7, 2027

Sponsor

Lead sponsor
Hippocration General HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
ReCor Medical, Inc.
First posted
Aug 3, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RDN-CKD GR Study is a prospective, randomized (1:1), double-blind (unblinded interventionalist and blinded study team), sham controlled study. The purpose of the RDN-CKD GR Study is to demonstrate that renal denervation (RDN) effectively reduces 24-h ambulatory BP in 20 patients with chronic kidney disease (CKD) stage 3a or 3b.

Conditions

  • Uncontrolled Hypertension
  • Renal Denervation
  • Chronic Kidney Disease (Stage 3)

Interventions

  • Renal denervationDevice

    The Paradise® Renal Denervation System (Paradise System) is CE-marked in countries accepting the CE mark. The system is a catheter-based device designed to use ultrasound energy to thermally ablate the afferent and efferent nerves surrounding the renal artery and serving the kidney.

  • Sham procedure controlDiagnostic test

    sham procedure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. change in systolic 24-h ambulatory BPTime frame: at 6 month post-procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hippocratio General Hospital

    Athens, Greece

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.